ABIONYX Pharma SA (EPA:ABNX)
France
· Delayed Price · Currency is EUR 1.228
-0.042 (-3.31%)
Apr 1, 2025, 12:22 PM CET
ABIONYX Pharma Revenue
In the year 2024, ABIONYX Pharma had annual revenue of 4.60M EUR, down -0.86%. ABIONYX Pharma had revenue of 2.26M in the half year ending December 31, 2024, a decrease of -13.96%.
Revenue
4.60M
Revenue Growth
-0.86%
P/S Ratio
n/a
Revenue / Employee
75.41K
Employees
61
Market Cap
44.04M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 44.29B |
| EssilorLuxottica Société anonyme | 26.51B |
| Sartorius Stedim Biotech | 2.78B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.43B |